Becton, Dickinson reported fourth-quarter fiscal 2026 revenue of $5.3 billion, a 5.4% increase as reported and 5.6% foreign currency neutral. Adjusted diluted earnings per share for the quarter were $4.15, up from $3.26 in the prior year period. For the full fiscal year 2026, revenue reached $19.5 billion with adjusted diluted EPS of $12.70. The company also issued fiscal 2027 guidance for low single-digit revenue growth and adjusted diluted EPS between $13.10 and $13.30. BD operates as a leading global medical technology company.
